MedPath

The 28 Day Challenge

Not Applicable
Withdrawn
Conditions
Hope
Depression
Stress
Anxiety
Interventions
Behavioral: Audio Content 2
Behavioral: Audio Content 1
Registration Number
NCT03936946
Lead Sponsor
Stanford University
Brief Summary

The purpose of this study is to determine how a 28 Day Challenge influences mental health and well-being. This is a blinded study. Participants both with and without depression and anxiety, will be included. A moderation analysis will be performed to see whether changes in depression after the intervention are a function of baseline depression and anxiety levels.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • English Fluency
Read More
Exclusion Criteria
  • Severe hearing impairment
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 3--October Start Audio Content 2Audio Content 2This group will listen to audio content 2 daily for 28 days beginning in October, and then will receive no further intervention.
Group 1--October Start Audio Content 1Audio Content 1This group will listen to audio content 1 daily for 28 days beginning in October, and then will receive no further intervention
Group 2--November Start Audio Content 1Audio Content 1This group will not be assigned to any interventions during the first month of the trial and will act as a passive control group at that time. They will be assigned to listen to audio content 1 daily for 28 days beginning in November.
Primary Outcome Measures
NameTimeMethod
Change in Perceived Stress Scale-10 (PSS-10)Baseline, 3 months

The Perceived Stress Scale-10 (PSS-10) measures global perceived stress via self-report on a ten item scale. Scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress. Total scores ranging from 0-13 would be considered low stress. Total scores ranging from 14-26 would be considered moderate stress. Total scores ranging from 27-40 would be considered high perceived stress.

Change in Generalized Anxiety Disorder-7 (GAD-7)Baseline, 3 months

The GAD-7 is a self report-based survey that assesses generalized anxiety disorder and severity on a 7-item scale. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. The GAD-7 was compared to diagnoses by mental health professionals. Using scores \>/= 10, It has sensitivity of 89% and specificity of 82%.

Change in Patient Heath Questionnaire-9 (PHQ-9)Baseline, 3 months

The PHQ-9 is a self-administered survey used for diagnosing depression and assessing depression severity. It measures each of the 9 DSM-IV/V diagnostic criteria for depression on a 0-3 scale. Depression Severity is measured as follows: 0 none, 1-4 minimal, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe. Validity has been assessed against structured clinical interviews. PHQ-9 scores ≥10 exhibited a sensitivity of 88% and a specificity of 88% for major depression.

DSM = The Diagnostic and Statistical Manual of Mental Disorders

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath